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1. Introduction  
Infections with non-typhoidal Salmonella are the second most common cause of bacterial 
gastroenteritis in developed countries, with the incidence of multidrug-resistant non-typhoidal 
Salmonella increasing considerably in the last two decades. Non-typhoidal salmonellosis in 
otherwise healthy individuals usually results in mild, self-limiting diarrhoea, but treatment 
with an appropriate antimicrobial can be life-saving in vulnerable patient groups such as the 
elderly, immunocompromised patients or those with underlying disease, and in cases of 
invasive disease such as Salmonella bacteraemia, osteomyelitis and meningitis.  
Aminoglycosides are often used in combination with broad-spectrum ß-lactams for the 
treatment of life-threatening infections due to both Gram-positive and Gram-negative 
bacteria due to their potent concentration-dependent bactericidal activity and postantibiotic 
effect, and their ability to act synergistically with many other antimicrobials (Lacy et al., 
1998). They have been classified as critically important antimicrobials in human medicine 
(World Health Organisation, 2007). By binding irreversibly to the highly-conserved 
aminoacyl (A-site) of the 16S ribosomal subunit they inhibit bacterial protein synthesis, 
thereby leading to cell death (Kotra et al., 2000). The most common mechanism for 
resistance to aminoglycosides results from production of aminoglycoside-modifying 
enzymes (phosphotransferases, nucleotidyltranferases and acetyltransferases), which 
compromise the binding of the aminoglycoside to the target site. Resistance may also result 
from reduced intracellular drug uptake and accumulation (likely to be due to changes in 
membrane permeability) or mutation of ribosomal proteins or rRNA (Mingeot-Leclercq et 
al., 1999). However, recent years have seen the emergence of several 16S rRNA 
methyltransferases in clinical isolates of Gram-negative bacteria in Europe, the Far East, and 
North and South America. 
2. Aminoglycoside resistance mediated by 16S rRNA methylation 
Aminoglycoside-producing actinomycetes are intrinsically resistant to very high levels (MIC 
>512 mg/L) of the aminoglycoside they produce due to rRNA methyltransferase enzymes, 
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but until recently no clinical isolate that was resistant to aminoglycosides as a result of an 
rRNA methyltransferase had been identified (Davies & Wright, 1997). The first reported 16S 
rRNA methyltransferase gene armA (aminoglycoside resistance methyltransferase) was 
identified in a multiresistant Klebsiella pneumoniae isolated in France (Galimand et al., 2003). 
A further seven enzymes have been associated with 16S rRNA methylation: rmtA 
(Yokoyama et al., 2003), rmtB (Doi et al., 2004), rmtC (Wachino et al., 2006a), rmtD (now 
renamed as rmtD1) (Doi et al., 2007), rmtD2 (shares 96.4% amino acid identity with rmtD1) 
(Tijet et al., 2011), rmtE (Davis et al., 2010) and npmA (Wachino et al., 2007). The deduced 
amino acid sequences show homology with 16S rRNA methyltransferases produced by 
Actinomycetales, including Streptomyces and Micromonospora spp. (Fig. 1). However, the 
degree of identity shared overall between the 16S rRNA methyltransferase genes is less than 
30%, which suggests that this is not a recent transfer event.  
 
Fig. 1. 16S rRNA methyltransferases conferring high-level resistance to aminoglycosides 
identified to date. 
3. Clinical relevance of 16S rRNA methyltransferases 
Unlike the aminoglycoside-modifying enzymes, which vary in their substrate specificity, 
16S rRNA methyltransferases armA and rmtA-E confer high-level resistance to all clinically-
important aminoglycosides used for systemic therapy except streptomycin; npmA confers 
high-level resistance mainly to 4,5, disubstituted deoxystreptamines like apramycin. These 
genes are linked with mobile genetic elements and usually confirmed as located on large 
conjugative plasmids, allowing potential spread among bacterial populations. In addition, 
they have been commonly associated with other genes encoding resistance to clinically 
relevant antimicrobials such as ß-lactams (blaSHV, blaCTX-M, plasmid-mediated AmpC), 
carbapenems (blaSPM-1, blaNDM-1, blaKPC-2) and fluoroquinolones (plasmid-mediated qepA, 
aac(6’)-Ib-cr and qnr family), thereby allowing potential co-selection and maintenance of 
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resistance by use of other antimicrobial agents. 16S rRNA methyltransferases have been 
identified in glucose non-fermentative Gram-negative bacilli and enterobacteria, including 
Salmonella enterica, isolated from clinical, veterinary and food sources. 
4. Detection of 16S rRNA methyltransferases 
4.1 Phenotypic detection 
armA and rmtA-E confer resistance to 4,6-disubstituted deoxystreptamines such as amikacin, 
kanamycin, tobramycin and gentamicin by methylation at position A1405 within the A-site 
of the 16S rRNA, whilst npmA confers panaminoglycoside resistance due to methylation at 
position A1408 (Liou et al., 2006; Wachino et al., 2007). 16S rRNA methyltransferase 
producers characteristically demonstrate aminoglycoside MICs 256 mg/L and are unique 
in expressing high-level resistance to the semisynthetic aminoglycoside arbekacin (Doi & 
Arakawa, 2007). Production of a 16S rRNA methyltransferase should be expected in 
enterobacteria exhibiting resistance to multiple aminoglycosides according to Clinical and 
Laboratory Standards Institute (CLSI) guidelines and demonstrating little or no inhibitory 
zones when using gentamicin, amikacin and arbekacin disks. Although arbekacin may not 
be readily available Doi & Arakawa (2007) noted that inclusion of an arbekacin disk was 
preferable as this increased the positive predictive value of this method to 90%, compared 
to only ca. 60% when using amikacin alone (Lee et al., 2006). Alternatively, using 
aminoglycoside MICs 256 mg/L as a screen has been reported to have an excellent positive 
predictive value (Lee et al., 2006; Doi & Arakawa; 2007). 
4.2 Molecular detection and characterization 
With the exception of npmA, phenotypic resistance traits cannot be used to differentiate 
between the 16S rRNA methyltransferase variants. Instead PCR amplification and 
comparison of the amplicon sequence to previously reported gene sequences must be used 
for confirmation. The published literature contains many PCR protocols for detection of 
these genes (Doi & Arakawa, 2007; Fritsche et al., 2008; Granier et al., 2011). 
5. 16S rRNA methyltransferases in Salmonella enterica 
Although all eight 16S rRNA methyltransferase genes have now been identified in 
enterobacteria; armA and rmtB are the most commonly identified and have spread 
worldwide. The first reported 16S rRNA methyltransferase gene in Salmonella enterica was 
armA in S. enterica serovar Enteritidis isolated in a hospital in Bulgaria (Galimand et al., 
2005). Transfer of high-level aminoglycoside resistance to an Escherichia coli recipient led to 
transconjugants expressing resistance to 4,6-disubstituted deoxystreptamines due to armA, 
to ß-lactams due to acquisition of blaTEM-1 and blaCTX-M-3, to streptomycin-spectinomycin 
because of ant”9, to sulphonamides because of sul1 and to trimethoprim because of dfrXII. 
All these resistance genes were located on a ca. 90-kb plasmid of incompatibility group 
IncL/M previously identified in Poland in Citrobacter freundii as pCTX-M3 (GenBank 
accession number AF550415; Gobiewski et al., 2007). Plasmid pCTX-M3 is responsible for 
the extensive spread of the extended-spectrum ß-lactamase (ESBL) blaCTX-M-3 in 
enterobacteria in Poland (including within S. enterica serovars Typhimurium, Enteritidis, 
Mbandaka and Oranienburg expressing very high-level resistance to aminoglycosides) 
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(Baraniak et al., 2002; Gierczynski et al., 2003a; Gierczynski et al., 2003b). The ant”9, sul1, 
dfrXII and armA genes were part of a 16.6-kb composite element flanked by two direct 
copies of IS6, which was designated Tn1548. Tn1548 has been identified on plasmids of 
other incompatibility groups and in enterobacteria of human and animal origin from several 
countries, thereby indicating its importance in the dissemination of armA (Galimand et al., 
2005; González-Zorn et al., 2005a; González-Zorn et al., 2005b).  
armA was also identified on a plasmid identical, or very similar to pCTX-M3 in a single 
isolate of S. enterica serovar Virchow among 1,078 non-typhoidal Salmonella isolates from 
patients hospitalized with gastroenteritis in Saint Petersburg, Russia between 2002-2005 
(Egorova et al., 2007). The armA gene associated with Tn1548 was also identified in one 
isolate of S. enterica serovar Stanley submitted in 1999 among a collection of 18,261 non-
typhoidal Salmonella isolated between 1996-2006 at the Centers for Disease Control and 
Prevention, USA (Folster et al., 2009).  
In 2004 an outbreak of diarrhoea occurred in the neonatology unit of the Hospital of 
Constantine in Algeria. Stool cultures yielded S. enterica serovar Senftenberg, which were 
resistant to amoxicillin, ticarcillin, piperacillin, cefalothin, extended-spectrum 
cephalosporins, trimethoprim-sulfamethoxazole, amikacin, gentamicin, netilmicin, 
tobramycin and streptomycin (Naas et al., 2005). Whilst Salmonella infections in hospitals are 
usually food-associated, in this instance spread of infection was likely to be due to 
horizontal transmission as the commercially prepared milk was fed to other babies that did 
not become infected. A subsequent screening of 12 representative ESBL-producing serovar 
Senftenberg isolates isolated from the ward between 1982-2005 that expressed resistance to 
aminoglycosides was performed (Naas et al., 2009). Only one isolate from 1998 that 
expressed resistance to all clinically-relevant aminoglycosides was found positive for armA; 
all other isolates were negative for 16S rRNA methyltransferase genes and showed variable 
levels of resistance to aminoglycosides. As before, armA was located within Tn1548 on a 
blaCTX-M-3-encoding IncL/M plasmid. 
Another outbreak occurred on the neonatology ward of the same hospital between 
September 2008 to January 2009 (Naas et al., 2011). S. enterica serovar Infantis isolates were 
obtained from 138 patients (mostly from stool cultures but two neonates had positive blood 
cultures and another had positive gastric fluid). All but two isolates were resistant to all ß-
lactams (except cephamycins and carbapenems), kanamycin, netilmicin, tobramycin, 
amikacin, gentamicin, rifampicin and trimethoprim/sulfamethoxazole. Molecular typing by 
pulsed-field gel electrophoresis (PFGE) of representative isolates indicated that they were 
genetically related. The presence of armA associated with Tn1548, together with blaCTX-M-15 
and blaTEM-1 was confirmed, with the 16S rRNA methyltransferase and ß-lactamase 
determinants co-located on a 140-kb self-transferable IncL/M plasmid. This suggests that 12 
years on, a plasmid similar to that identified in serovar Senftenberg was still present on the 
ward and may have transferred to serovar Infantis with the blaCTX-M-3 evolving to blaCTX-M-15 
via a single amino acid substitution (Asp-240→Gly) that has been associated with increased 
activity to ceftazidime (Poirel et al., 2002). Other enterobacterial species harbouring both 
armA, and blaCTX-M-3 or blaCTX-M-15 were isolated from Algerian patients transferred to 
Belgium (Bogaerts et al., 2007), and have been identified in Klebsiella spp. in Taiwan and 
China (Ma et al., 2009; Zhang et al., 2008), indicating that the Infantis plasmid may also have 
been acquired from a different bacterial species. Implementation and strengthening of 
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hygiene and infection control measures brought the outbreak under control but was 
insufficient to prevent further sporadic cases in 2009. These may have occurred after re-
hospitalisation of colonised patients or from re-introduction of the strain onto the ward by 
colonised members of staff. 
S. enterica serovars Typhimurium (n=13), 4,12:-:1,2 (n=1) and Enteritidis (n=4) co-
harbouring both blaCTX-M-15 and armA were identified in another study investigating the 
prevalence of 16S rRNA methyltransferase genes among ESBL-producing S. enterica 
isolates recovered in Annaba, Algeria between 2008-2009 (Bouzidi et al., 2011). Of the 18 
isolates, 13 belonging to serovars Typhimurium (n=12) and 4,12:-:1,2 (n=1) harboured 
blaCMY-2 and blaTEM in addition to blaCTX-M-15 and armA. PFGE analysis revealed these 12 
Typhimurium isolates shared an identical profile, indicating probable spread of an 
epidemic clone, whilst the four Enteritidis isolates shared three distinct profiles, 
suggesting horizontal transfer of the resistance determinants.  
The continuing spread of pCTX-M3-like plasmids in the Salmonella population was 
highlighted in the recent identification of serovar Gambia strains harbouring a ca. 80-kb 
IncL/M plasmid bearing armA and CTX-M-3 together with sulphonamide and trimethoprim 
resistance determinants in France (Moissenet et al., 2011). The strains isolated from two 
babies in the intensive care unit of a Paris hospital in 2005 shared identical resistance 
profiles (resistance to cefotaxime, ceftazidime, gentamicin, tobramycin, amikacin and co-
trimoxazole) and indistinguishable PFGE patterns. Given the rarity of serovar Gambia it 
was concluded that the second baby acquired the strain via cross-infection. Both babies had 
underlying disease and whilst the first baby was successfully treated with imipenem and 
ciprofloxacin, the second baby developed further complications and died despite broad-
spectrum therapy with imipenem, gentamicin, metronidazole and vancomycin. This was the 
first report of a fatality associated with non-typhoidal Salmonella harbouring a 16S rRNA 
methyltransferase gene. 
6. Enhanced surveillance for 16S rRNA methyltransferases in Salmonella 
enterica  
Between March 2006 and December 2009 a retrospective screen to identify 16S rRNA 
methyltransferase-producing enterobacteria among the strain collections of veterinary, 
medical and food science research institutes in ten European Union (EU) countries was 
performed under the auspices of the European-funded MED-VET-NET Network of 
Excellence. Isolates were selected for further study from nearly one million bacterial isolates 
from all sources along the food chain, including the environment, food-production animals, 
food products and humans based on expression of high-level resistance (MIC >256 mg/L) to 
amikacin or gentamicin. PCR using a harmonized protocol was used to screen selected 
isolates for the presence of armA. 
Among 46 S. enterica isolates selected from the culture collection of the Health Protection 
Agency (HPA), UK, five serovar Oranienburg isolates received in 2002 from Poland were 
positive for armA (Hopkins et al., 2007). A ca. 90-kb IncL/M conjugative plasmid, which 
harboured both armA and blaCTX-M-3 was isolated, with armA borne by Tn1548 as 
previously described. Transposon mapping using PCR producing overlapping amplicons 
along the length of the transposon indicated that the transposon structure was identical to 
that of pCTX-M3 (Fig. 2).  
 




Fig. 2. PCR-mapping of Tn1548, the genetic platform of armA. Note that pB1010 has been 
identified in Salmonella from food (Granier et al, 2011). 
S. enterica serovar Oranienburg harbouring blaCTX-M-3 and expressing resistance to 
aminoglycosides has previously been isolated in Poland, where armA is estimated to be 
present in ca. 1.6% of human clinical isolates of enterobacteria (Gierczynski et al., 2003a; 
Gierczynski et al., 2007). These five isolates were part of an outbreak of enteritis associated 
with an orphanage for infants and children below two years of age in central Poland. The 
orphanage was reported to provide poor living conditions (due to a high concentration of 
children) and sanitary standards (i.e. overuse of antimicrobials). Infected children were 
hospitalised in three separate hospitals in central Poland (Table 1). In total, 52 related 
isolates were obtained as reported by a local sanitary and epidemiological unit. Until 
recently this was the only report of involvement of an armA-positive Salmonella strain in a 
hospital outbreak (Naas et al., 2009). 
Strain identifier Patient age (months) Patient symptomatic? Other information 
9/01 7 Y 
living at the orphanage; 
hospitalised in Unit A 
11/01 3 Y 
living at the orphanage; 
hospitalised in Unit B 
36/01 11 Y 
living with parents – no 
known link to the 
orphanage 
57/01 7 N living in the orphanage 
79/01 11 Y 
living with parents – no 
known link to the 
orphanage; hospitalised in 
Unit C. 
Table 1. Epidemiological data on S. enterica serovar Oranienburg strains  
A further 13 isolates of non-typhoidal Salmonella were selected based on high-level 
resistance to amikacin from 81,632 HPA non-typhoidal Salmonella isolated between 2004-
16S rRNA Methyltransferases: An Emerging  
Resistance Mechanism Against Aminoglycosides in Salmonella 
 
245 
2008 (Hopkins et al., 2010). All isolates belonged to serovar Virchow of phage types 25 (n=6), 
30 (n=5) or 31 (n=1). PCR was negative for armA; however screening for rmtA, rmtB, rmtC 
and rmtD identified rmtC (Doi & Arakawa, 2007). RmtC has previously been identified in 
Proteus mirabilis strain ARS68 from an inpatient in Japan (Wachino et al., 2006a) and P. 
mirabilis strain JIE273 from a patient recently returned from India to Australia (Zong et al., 
2008), therefore this was the first report of rmtC in Europe. Twelve of the 13 strains were 
isolated from patients between 2005-2008, of which seven had reported recent travel abroad 
(four to India). S. enterica serovar Virchow expressing rmtC has also been reported in the 
United States in a child with a history of travel to India (Folster et al., 2009), suggesting that 
16S rRNA methyltransferases may be relatively common in India. The remaining isolate was 
obtained from frozen produce. This was the first report of a 16S rRNA methyltransferase 
gene being identified in a bacterial strain isolated from food. Interestingly, a survey in 
Northern India identified S. enterica in 3.6% of vegetable samples; however >30% of isolates 
were resistant to amikacin (Singh et al., 2007). PFGE revealed the 13 isolates were highly 
related, showing only one to two band differences; the isolate from frozen produce was 
indistinguishable from those isolated from patients. Attempts to isolate rmtC by conjugation 
and electroporation experiments were unsuccessful and the gene was eventually discovered 
located on the chromosome in association with an ISEcp1-like element, which has previously 
been shown to play a role in the expression and transposition of rmtC (Wachino et al., 
2006b). The rmtC gene was localised on a ca. 100-kb non-conjugative plasmid in P. mirabilis 
ARS68, but attempts to transfer rmtC from P. mirabilis JIE273 to a donor were unsuccessful. 
This contrasts with armA and rmtB, which are commonly localised on plasmids (Doi & 
Arakawa, 2007) and may explain at least in part the higher prevalence and increased 
dissemination of these genes in comparison to rmtC. rmtC-positive strains of S. enterica 
serovar Virchow belonging to the same phage types are still being received at the HPA from 
patients reporting recent return from India, suggesting persistence of this multidrug-
resistant clone (Hopkins, unpublished observation). 
Further evidence for food being a possible vehicle of infection for bacterial strains 
harbouring 16S rRNA methyltransferase genes was provided by a recent study reporting the 
identification of armA in a S. enterica serovar 4,12:i:- isolate recovered from chicken meat in 
La Réunion, a French island in the Indian Ocean (Granier et al., 2011). This was the first 
report of armA in a bacterial isolate originating from food. As well as armA, the isolate 
harboured blaCTX-M-3, blaTEM, the Salmonella Genomic Island-1 (as previously associated with 
multidrug-resistant Salmonella enterica serovar Typhimurium definitive phage type (DT) 104 
(Boyd et al., 2000)), and acquired AmpC ß-lactamase blaCMY-2. Conjugation experiments 
indicated that armA, blaCTX-M-3 and blaTEM were located on the same plasmid. However, 
further characterisation revealed that, in contrast to previous studies, these genes were 
located on a ca. 110-kb incompatibility group IncP plasmid. IncP plasmids have a broad host 
range, including Pseudomonas spp. and Gram-positive bacteria, therefore association with an 
IncP plasmid may further broaden the dissemination of armA. Transposon mapping using 
PCR also suggested a deletion event downstream of armA and insertion of an IS26 element, 
which knocked out genes encoding a macrolide resistance efflux pump and macrolide 
phosphotransferase gene (Fig. 2 and Fig. 3). Investigation of other S. enterica serovar 4,12:i:- 
isolates recovered from broiler chickens failed to identify any expressing high-level 
resistance to aminoglycosides, therefore it is likely that this strain was present in the chicken 
meat sample as a consequence of cross-contamination by a food-handler.  
 





Fig. 3. Schematic representation of the genetic structure of Tn1548 reported from an animal 
isolate (pMUR050), a human isolate(pCTX-M-3), and a food isolate of Salmonella enterica 
(pB1010). Blackarrows in the upper part of the panel represent pairs of primers designed for 
the mapping of Tn1548. (Granier et al., 2011) 
7. Conclusion 
The worldwide prevalence of S. enterica harbouring 16S rRNA methyltransferase genes is 
very low; however within the EU, Poland appears to represent a major reservoir of these 
genes. The majority of S. enterica isolates have been from nosocomial diarrhoeal outbreaks, 
with the occurrence of these genes in aminoglycoside-resistant strains from community 
patients relatively rare. Interestingly, veterinary use of aminoglycosides in food-production 
animals does not appear to be involved greatly in the spread of 16S rRNA methyltransferase 
genes as had previously been hypothesized in the literature (González-Zorn et al., 2005a). 
Food products have recently been identified as a source of S. enterica harbouring 16S rRNA 
methyltransferase genes (Hopkins et al., 2010; Granier et al., 2011), though whether this is an 
indication of an animal source of these genes, or cross contamination by food handlers has 
yet to be elucidated. Further evolution and dissemination of these genes may be limited to 
environments such as hospitals, and countries in which antimicrobial usage is unregulated 
where a strong selective pressure results from high-level use of a diverse range of 
aminoglycosides. This is compounded by their common association with other resistance 
genes, leading to potential co-selection and maintenance of resistance by use of extended-
spectrum ß-lactams, carbapenems and fluoroquinolones (Cantón, 2009). Spread of 16S rRNA 
methyltransferase genes in association with these resistance genes would seriously 
compromise use of aminoglycosides for treatment of life-threatening infections caused by 
Gram-negative bacteria such as S. enterica and raises the possibility of untreatable Salmonella 
infections. Ongoing surveillance of aminoglycoside resistance in S. enterica isolated from 
humans, animals and food products is therefore crucial to delay the spread of resistance to 
these classes of antimicrobial agents. 
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